DexCom, Inc. (DXCM) Financials
DXCM Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 6.5 billion | 4.2 billion |
2023-12-31 | 6.3 billion | 4.2 billion |
2023-09-30 | 6.6 billion | 4.3 billion |
2023-06-30 | 6.8 billion | 4.7 billion |
DXCM Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | 152.3 million | 39.0 million |
2023-12-31 | 81.1 million | 36.9 million |
2023-09-30 | 218.8 million | 39.0 million |
2023-06-30 | 131.3 million | 39.7 million |
DXCM Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2024-03-31 | 146.4 million |
2023-12-31 | 256.3 million |
2023-09-30 | 120.7 million |
2023-06-30 | 115.9 million |
DXCM Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 2.9 billion | - | 154.1 million |
2023-12-31 | 2.7 billion | - | 159.8 million |
2023-09-30 | 3.2 billion | - | 104.4 million |
2023-06-30 | 3.6 billion | 2.4 billion | 108.7 million |
DXCM Shares Outstanding
DXCM Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 56.9 million | 141.5 million | 319.3 million | - |
2023-12-31 | 52.5 million | 136.1 million | 128.0 million | 180.8 million |
2023-09-30 | 50.4 million | 131.4 million | 284.7 million | - |
2023-06-30 | 59.0 million | 119.3 million | 297.3 million | - |
DXCM Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 921.0 million | 359.1 million |
2023-12-31 | 1.0 billion | 377.9 million |
2023-09-30 | 975.0 million | 351.7 million |
2023-06-30 | 871.3 million | 324.9 million |
DXCM
Price: $124.34
52 week price:
Earnings Per Share: 1.29 USD
P/E Ratio: 139.13
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Volume: 3.0 million
Ebitda: 6.3 millionMarket Capitalization: 49.4 billion